Danaher's Shares Soar Amid Biotech Spending Rebound
Tuesday, 23 April 2024, 18:19
Danaher Stock Surges 7% on Positive Biotech Turnaround
There was much more to like in this print, including strong headline results on the back of strength in all key operating segments.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.